High-stakes cholesterol study could lift Merck cloud

[riky]

High-stakes cholesterol study could lift Merck cloud

NEW YORK (Reuters) - Favorable results from a huge heart study could help redeem investors' faith in Merck & Co and its two biggest cholesterol drugs, Vytorin and Zetia, and potentially add billions of dollars in annual revenue. Investors have soured on the No. 2 U.S. drugmaker since late December, following setbacks to a closely watched experimental drug for osteoporosis and a newer cholesterol medicine. ...

Source: You are not allowed to view links. Register or Login